# Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast Cancer

> **NCT00559858** · PHASE3 · UNKNOWN · sponsor: **Cambridge University Hospitals NHS Foundation Trust** · enrollment: 270 (estimated)

## Conditions studied

- Breast Cancer
- Colorectal Cancer
- Palmar-plantar Erythrodysesthesia

## Interventions

- **DIETARY_SUPPLEMENT:** pyridoxine hydrochloride
- **OTHER:** placebo
- **PROCEDURE:** quality-of-life assessment

## Key facts

- **NCT ID:** NCT00559858
- **Lead sponsor:** Cambridge University Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-12
- **Primary completion:** 2009-12
- **Final completion:** —
- **Target enrollment:** 270 (ESTIMATED)
- **Last updated:** 2013-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00559858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00559858, "Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00559858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*